Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +47.86%
#3 Velvet Velvet +43.20%
#4 Akedo Akedo +42.96%
#5 Black Phoenix Black Phoenix +34.22%
#6 Cross Cross +21.95%
#7 DoubleZero DoubleZero +17.10%
#8 Cap Cap +16.75%
#9 Tutorial Tutorial +15.51%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.76%
Coin of the day
Islamic Coin Islamic Coin
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Rang în acțiuni #33956
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Preț acțiune
$17.15
Ultima sincronizare: 2026-08-03
Capitalizare de piață
$6.51M
Schimbare (1 zi)
9.80%
Schimbare (1 an)
289.77%
Țară
US
Tranzacționează Galera Therapeutics, Inc. (GRTX)

Categorie

Healthcare
Raport P/S pentru Galera Therapeutics, Inc. (GRTX)
Raport P/S la data de August 2026 TTM: 0.00
Conform celor mai recente rapoarte financiare și prețului acțiunilor Galera Therapeutics, Inc., raportul P/S actual (TTM) este 0.00. La sfârșitul anului 2023, compania avea un P/S de 0.00.
Istoricul raportului P/S pentru Galera Therapeutics, Inc. din 2017 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE